拖延症（学术上称为“自我调节失败”）不仅带来心理负担，还造成显著的经济与健康损失。2013年一项对22053人进行的研究表明，拖延评分每增加1分，年收入就会减少近15000美元；2023年针对3525名瑞典大学生的研究发现，高拖延人群更容易患上严重疼痛、焦虑、压力与孤独；2025年发表在《心理学前沿》涵盖17个国家88项研究及63323名受访者的元分析证实，拖延引发的自尊侵蚀是预测未来抑郁症的重要指标。
为了应对拖延，心理干预与体育锻炼展现出明确的效果。“结合执行意图的心理对比”（MCII）训练要求个体想象目标成果、识别核心障碍并制定应对策略；2020年针对本科生的随机试验显示，进行MCII训练的受试者每晚推迟入睡的时间比对照组减少了约38分钟。此外，中国2024年针对77名青少年及2022年针对564名大学生的研究均表明，经过12周力量与高强度间歇训练或保持高体育活跃度的群体拖延行为显著减少，运动带来的掌控感有效提升了自信与行动力。
生活习惯与药物研发也为解决拖延提供了新视角。2024年针对意大利大学生的研究表明，不吃早餐、过量饮酒和睡眠质量差的群体拖延程度更高。在药物方面，虽然目前尚无专门针对拖延症的特效药，但2021年一项针对成人注意缺陷多动障碍（ADHD）的随机对照试验发现，服用中枢神经兴奋剂赖氨酸安非他命（lisdexamfetamine）的受试者在启动任务等认知执行功能方面表现出显著改善。鉴于现代远程办公与智能手机泛滥加剧了拖延风险，进一步的科学干预研究显得尤为迫切。
Procrastination, defined scientifically as self-regulatory failure, imposes severe financial and health costs. A 2013 study of 22,053 individuals revealed that a one-point increase on a five-point procrastination scale correlates with a nearly $15,000 drop in annual earnings. Further research, including a 2023 study of 3,525 Swedish students and a 2025 meta-analysis covering 88 studies across 63,323 people in 17 countries, links high procrastination to chronic pain, anxiety, sleep loss, and an increased long-term risk of depression driven by eroded self-esteem.
Mental exercises and physical exercise offer proven strategies to combat delayed action. Mental contrasting with implementation intentions (MCII) encourages individuals to visualize goals, identify obstacles, and form specific action plans; in 2020 trials, undergraduates using online MCII modules reduced bedtime procrastination by approximately 38 minutes nightly compared to control groups. Additionally, Chinese clinical trials involving teenagers and university students demonstrated that 12 weeks of strength and high-intensity interval training yielded significant reductions in procrastination by enhancing self-efficacy and executive control.
Habitual factors and pharmacological interventions also influence task initiation. A 2024 study among Italian university students associated higher procrastination rates with skipping breakfast, alcohol consumption, and poor sleep quality. While no drug is currently approved specifically for procrastination, a 2021 randomized controlled trial in adults with ADHD showed that the stimulant lisdexamfetamine significantly improved cognitive executive function and task initiation, highlighting potential therapeutic pathways as remote work and smartphone distractions proliferate.
Source: How to stop procrastinating
Subtitle: Thwarting the thief of time
Dateline: 8月 06, 2026 04:02 上午